Global Dry Eye Syndrome Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast to 2028
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
The dry eye syndrome market is anticipated to grow with a CAGR of 6% over the forecast period of 20202028. According to a study published by Insure Insights on the dry eye syndrome market, the rise in the geriatric population and the increasing awareness associated with the disease are considered some of the driving factors for the markets growth. Additionally, the development of contact lenses and the high adoption of these lenses by individuals are also boosting the growth of the market.
The Dry Eye Syndrome is being driven by the rising prevalence of the condition as well as technological advancement. Market
A dry eye is a type of condition in which an individual doesnt have adequate quality and amount of tears to lubricate and nourish the eye. Tears are essential for maintaining the health of the front surface of the eye, which leads to providing clear vision. These types of issues are commonly found among the geriatric population. According to a study published in February 2019 by the American Journal of Ophthalmology, the annual prevalence of dry eye syndrome was estimated to increase from 0.8% to 3.0% overall, including male and female beneficiaries. The female recipients were found to be more prone to the disease than the male recipients. The rise in the prevalence of this chronic disease is one of the major factors driving the growth of the market. Furthermore, the increase in various diseases such as hyperalgesia, spontaneous pain, and allodynia, suggesting dysfunction of the ocular sensory apparatus and others, also impacts the lacrimal functional unit that results in changing basal and reflex tear secretion, causing the eyes to go dry.
Similarly, the high prevalence of other conditions, including diabetes, is another major factor that is advancing the prevalence of dry eye syndrome. The changes in the composition of the individuals blood due to diabetes can affect tear glands and may cause dry eye syndrome. Furthermore, other conditions, such as thyroid disorders, vitamin A deficiency, lupus, and rheumatoid arthritis, may also cause dry eye syndrome. Additionally, the increase in investments by the government and private companies for the development of a cure for the syndrome is also impacting the growth of the market positively.
Retail Pharmacies to Play a Key Role in the Global Dry Eye Syndrome Market Growth
Based on the distribution channel, the dry eye syndrome market has been segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. Due to the presence of various retail pharmacies across the globe, the retail pharmacies segment holds the largest share of the dry eye syndrome market in the distribution channel segment. Additionally, the rise in the segment is due to the presence of multiple drugs and solutions for chronic diseases. Additionally, lubricant eye drops, artificial tears, punctual bags, and medications for dry eye syndrome are readily available in the retail pharmacies of various brands, which are driving the growth of the market.
Based on type, the global dry eye syndrome market has been segmented into evaporative dry eye syndrome and aqueous dry eye syndrome. The evaporative dry eye syndrome holds the largest share of the type segment as these types of the syndrome is more common among the elderly population. Furthermore, these types of syndromes are the most common that most individuals face. Thus, to overcome these issues, the companies have developed artificial tears that are expected to boost the growth of the market.
The market is being driven by North Americas established healthcare industry.
Due to its well-developed facilities and infrastructure, North America dominates the dry eye syndrome market across the regions. Similarly, the presence of a large patient population affected by this syndrome and increasing healthcare expenditure are also driving the growth of the market. The presence of various gigantic players such as Johnson & Johnson Vision, Acadia Pharmaceutical, Auven Therapeutics, and others within the region is also driving the growth of the market. Additionally, the presence of countries such as the US and Canada, which have major healthcare systems with well-established hospitals, clinics, and other healthcare manufacturing units, is helping to drive the growth of the market.
Players to Focus on the Development of New Solutions
The global dry eye syndrome market is expected to grow with a significant CAGR due to the presence of various companies, including Johnson & Johnson Vision, Acadia Pharmaceutical, Allostera Pharma, I-Med Pharma Inc., Allergan, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Valent Pharmaceuticals, Santen Pharmaceuticals Co. Ltd., AFT pharmaceuticals, NovaliqGmBH, Auven Therapeutics, and others, which are developing new solutions to overcome these syndromes that are boosting the market growth.
In June 2019, Oxford Biomedica plc entered into an R & D collaboration and signed an option and license agreement to start research and development on gene therapy products that will eventually lead to the treatment of inherited retinal disease.
Alcon Inc.: In December 2018, Alcon Inc., an eye care division of Novartis, acquired Tear Film Innovations, Inc. This acquisition leads Alcon to global expansion and strengthens its product portfolio in ocular health products and provides treatment for dry eye syndrome.
Scope of the Report
By Type
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
By Product
Anti-inflammatory
Artificial Tears
Lubricants
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
Europe
Asia Pacific
Rest of the World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
The Dry Eye Syndrome is being driven by the rising prevalence of the condition as well as technological advancement. Market
A dry eye is a type of condition in which an individual doesnt have adequate quality and amount of tears to lubricate and nourish the eye. Tears are essential for maintaining the health of the front surface of the eye, which leads to providing clear vision. These types of issues are commonly found among the geriatric population. According to a study published in February 2019 by the American Journal of Ophthalmology, the annual prevalence of dry eye syndrome was estimated to increase from 0.8% to 3.0% overall, including male and female beneficiaries. The female recipients were found to be more prone to the disease than the male recipients. The rise in the prevalence of this chronic disease is one of the major factors driving the growth of the market. Furthermore, the increase in various diseases such as hyperalgesia, spontaneous pain, and allodynia, suggesting dysfunction of the ocular sensory apparatus and others, also impacts the lacrimal functional unit that results in changing basal and reflex tear secretion, causing the eyes to go dry.
Similarly, the high prevalence of other conditions, including diabetes, is another major factor that is advancing the prevalence of dry eye syndrome. The changes in the composition of the individuals blood due to diabetes can affect tear glands and may cause dry eye syndrome. Furthermore, other conditions, such as thyroid disorders, vitamin A deficiency, lupus, and rheumatoid arthritis, may also cause dry eye syndrome. Additionally, the increase in investments by the government and private companies for the development of a cure for the syndrome is also impacting the growth of the market positively.
Retail Pharmacies to Play a Key Role in the Global Dry Eye Syndrome Market Growth
Based on the distribution channel, the dry eye syndrome market has been segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. Due to the presence of various retail pharmacies across the globe, the retail pharmacies segment holds the largest share of the dry eye syndrome market in the distribution channel segment. Additionally, the rise in the segment is due to the presence of multiple drugs and solutions for chronic diseases. Additionally, lubricant eye drops, artificial tears, punctual bags, and medications for dry eye syndrome are readily available in the retail pharmacies of various brands, which are driving the growth of the market.
Based on type, the global dry eye syndrome market has been segmented into evaporative dry eye syndrome and aqueous dry eye syndrome. The evaporative dry eye syndrome holds the largest share of the type segment as these types of the syndrome is more common among the elderly population. Furthermore, these types of syndromes are the most common that most individuals face. Thus, to overcome these issues, the companies have developed artificial tears that are expected to boost the growth of the market.
The market is being driven by North Americas established healthcare industry.
Due to its well-developed facilities and infrastructure, North America dominates the dry eye syndrome market across the regions. Similarly, the presence of a large patient population affected by this syndrome and increasing healthcare expenditure are also driving the growth of the market. The presence of various gigantic players such as Johnson & Johnson Vision, Acadia Pharmaceutical, Auven Therapeutics, and others within the region is also driving the growth of the market. Additionally, the presence of countries such as the US and Canada, which have major healthcare systems with well-established hospitals, clinics, and other healthcare manufacturing units, is helping to drive the growth of the market.
Players to Focus on the Development of New Solutions
The global dry eye syndrome market is expected to grow with a significant CAGR due to the presence of various companies, including Johnson & Johnson Vision, Acadia Pharmaceutical, Allostera Pharma, I-Med Pharma Inc., Allergan, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Valent Pharmaceuticals, Santen Pharmaceuticals Co. Ltd., AFT pharmaceuticals, NovaliqGmBH, Auven Therapeutics, and others, which are developing new solutions to overcome these syndromes that are boosting the market growth.
In June 2019, Oxford Biomedica plc entered into an R & D collaboration and signed an option and license agreement to start research and development on gene therapy products that will eventually lead to the treatment of inherited retinal disease.
Alcon Inc.: In December 2018, Alcon Inc., an eye care division of Novartis, acquired Tear Film Innovations, Inc. This acquisition leads Alcon to global expansion and strengthens its product portfolio in ocular health products and provides treatment for dry eye syndrome.
Scope of the Report
By Type
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
By Product
Anti-inflammatory
Artificial Tears
Lubricants
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region
North America
Europe
Asia Pacific
Rest of the World
Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
TABLE OF CONTENTS
Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Global Dry Eye Syndrome Market Forces
3.1 Whats Driving the Market
3.2 Porters Five Forces Analysis
3.2.1 Power of Suppliers
3.2.2 Threats From New Entrants
3.2.3 Power of Buyer
3.2.4 Threat From Substitute Product
3.2.5 Degree of Competition
Chapter 4 Global Dry Eye Syndrome Market -Industry Snapshots
4.1 Overview
4.1.1 Global Dry Eye Syndrome Market Value, 2019 - 2030, (US$ Mn)
4.2 Market Overview
4.2.1 Drivers Analysis
4.2.2 Restraint/Challenges analysis
4.2.3 Opportunity Analysis
4.3 Supply Chain/Value Chain Analysis
4.4 Market SWOT Analysis
Chapter 5 Global Dry Eye Syndrome Market Analysis, By Type
5.1 Overview
5.2 Evaporative Dry Eye Syndrome
5.3 Aqueous Dry Eye Syndrome
Chapter 6 Global Dry Eye Syndrome Market Analysis, by Product
6.1 Overview
6.1.1 Anti-inflammatory
6.1.2 Artificial Tears
6.1.3 Lubricants
Chapter 7 Global Dry Eye Syndrome Market Analysis, by Distribution Channel
7.1 Overview
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.1.4 Others
Chapter 8 Dry Eye Syndrome Market Analysis by Region
8.1 Key Findings for Dry Eye Syndrome Market- By region
8.2 Overview
8.2.1 Global Dry Eye Syndrome Market Analysis, By Type, 2019 - 2030
8.2.2 Global Dry Eye Syndrome Market Analysis, By Product, 2019 - 2030
8.2.3 Global Dry Eye Syndrome Market Analysis, By Distribution Channel, 2019 - 2030
8.3 Dry Eye Syndrome Market North America
8.3.1 Overview
8.3.2 U.S.
8.3.3 Canada
8.3.4 Mexico
8.4 Dry Eye Syndrome Market Europe
8.4.1 Overview
8.4.2 Germany
8.4.3 United Kingdom
8.4.4 France
8.4.5 Italy
8.4.6 Rest Of Europe
8.5 Dry Eye Syndrome Market Asia Pacific
8.5.1 Overview
8.5.2 China
8.5.3 Japan
8.5.4 India
8.5.5 Rest of APAC
8.6 Dry Eye Syndrome Market Rest of the World
8.6.1 Overview
8.6.2 Middle East & Africa (MEA)
8.6.3 Latin America
Chapter 9 Market Competition Analysis
9.1 Market Share/Positioning Analysis
9.1.1 Market Positioning of Key Dry Eye Syndrome Vendors, 2018
9.1.2 Key Strategies Adopted by the Leading Players
Chapter 10 Company Profiles- Snapshot
10.1 Allergan
10.2 Novartis AG
10.3 Otsuka Pharmaceutical Co. Ltd.
10.4 Valent Pharmaceuticals
10.5 Johnson & Johnson Vision
10.6 Acadia Pharmaceutical
10.7 Allostera Pharma
10.8 I-Med Pharma Inc.
10.9 Santen Pharmaceuticals Co. Ltd.
10.10 AFT pharmaceuticals
10.11 Novaliq GmBh
10.12 Auven therapeutics
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 11 Appendix
11.1 Research Methodology
11.2 Data Triangulation
11.3 Data Sources
11.4 Assumptions
11.5 Approach Adopted
11.6 Disclaimer
TABLE 2 Dry Eye Syndrome Market, By Aqueous Dry Eye Syndrome, 2018 - 2026 (USD Million)
TABLE 3 Dry Eye Syndrome Market By Anti-inflammatory, 2018 - 2026 (USD Million)
TABLE 4 Dry Eye Syndrome Market By Artificial Tears, 2018 - 2026 (USD Million)
TABLE 5 Dry Eye Syndrome Market By Lubricants, 2018 - 2026 (USD Million)
TABLE 6 Dry Eye Syndrome Market By Hospital Pharmacies, 2018 - 2026 (USD Million)
TABLE 7 Dry Eye Syndrome Market By Retail Pharmacies, 2018 - 2026 (USD Million)
TABLE 8 Dry Eye Syndrome Market By Online Pharmacies, 2018 - 2026 (USD Million)
TABLE 9 Dry Eye Syndrome Market By Others, 2018 - 2026 (USD Million)
TABLE 10 Global Dry Eye Syndrome Market Value, By Type, 2019 - 2030 (US$ Mn)
TABLE 11 Global Dry Eye Syndrome Market Value, By Product, 2019 - 2030 (US$ Mn)
TABLE 12 Global Dry Eye Syndrome Market Value, By Distribution Channel, 2019 - 2030 (US$ Mn)
TABLE 13 Dry Eye Syndrome Market Analysis by North America, By Country (USD Million), 2018-2026
TABLE 14 U.S. Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 15 U.S. Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 16 U.S. Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 17 Canada Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 18 Canada Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 19 Canada Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 20 Mexico Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 21 Mexico Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 22 Mexico Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 23 Dry Eye Syndrome Market Analysis by Europe by Country (USD Million), 2018-2026
TABLE 24 Germany Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 25 GermanyDry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 26 Germany Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 27 United Kingdom Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 28 United Kingdom Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 29 United Kingdom Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 30 France Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 31 France Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 32 France Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 33 Italy Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 34 Italy Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 35 Italy Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 36 Rest Of Europe Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 37 Rest Of Europe Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 38 Rest of Europe Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 39 Dry Eye Syndrome Market Analysis by Asia Pacific by Country (USD Million), 2018-2026
TABLE 40 China Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 41 China Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 42 China Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 43 Japan Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 44 Japan Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 45 Japan Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 46 IndiaDry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 47 IndiaDry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 48 India Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 49 Rest of APAC Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 50 Rest of APAC Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 51 Rest of APAC Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 52 Dry Eye Syndrome Market Analysis by Rest of the World , by Region(USD Million), 2018-2026
TABLE 53 Middle East & Africa (MEA)Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 54 Middle East & Africa (MEA)Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 55 Middle East & Africa (MEA)Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 56 Latin America Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 57 Latin America Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 58 Latin America Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
FIG. 2 Global Dry Eye Syndrome Market Value, 2019 - 2030, (US$ Mn)
FIG. 3 Global Dry Eye Syndrome Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 4 Global Dry Eye Syndrome Market Value Contribution, By Product, 2019 & 2026 (%)
FIG. 5 Global Dry Eye Syndrome Market Value Contribution, By Distribution Channel, 2019 & 2026 (%)
FIG. 6 Global Dry Eye Syndrome Market Value, 2019 - 2030, (US$ Mn)
FIG. 7 North America Dry Eye Syndrome Market By Country (USD Million), 2019 - 2030
FIG. 8 Dry Eye Syndrome By Type North America
FIG. 9 Dry Eye Syndrome Market By Product North America
FIG. 10 Dry Eye Syndrome By Distribution Channel North America
FIG. 11 Dry Eye Syndrome U.S. outlook, 2019 & 2026
FIG. 12 Dry Eye Syndrome Canada outlook, 2019 & 2026
FIG. 13 Dry Eye Syndrome Mexico outlook, 2019 & 2026
FIG. 14 Europe Dry Eye Syndrome Market By Country (USD Million), 2019 - 2030, (US$ Mn)
FIG. 15 Dry Eye Syndrome Market Type Europe
FIG. 16 Dry Eye Syndrome Market Product Europe
FIG. 17 Dry Eye Syndrome Market Distribution Channel Europe
FIG. 18 Dry Eye Syndrome Germany outlook, 2019 & 2026
FIG. 19 Dry Eye Syndrome United Kingdom outlook, 2019 & 2026
FIG. 20 Dry Eye Syndrome France outlook, 2019 & 2026
FIG. 21 Dry Eye Syndrome Italy outlook, 2019 & 2026
FIG. 22 Dry Eye Syndrome Rest Of Europe outlook, 2019 & 2026
FIG. 23 Asia Pacific Dry Eye Syndrome Market By Country (USD Million), 2019 - 2030
FIG. 24 Dry Eye Syndrome Market Type Asia Pacific
FIG. 25 Dry Eye Syndrome Market Product Asia Pacific
FIG. 26 Dry Eye Syndrome Market Distribution Channel Asia Pacific
FIG. 27 Dry Eye Syndrome China outlook, 2019 & 2026
FIG. 28 Dry Eye Syndrome Japan outlook, 2019 & 2026
FIG. 29 Dry Eye Syndrome India outlook, 2019 & 2026
FIG. 30 Dry Eye Syndrome Rest of APAC outlook, 2019 & 2026
FIG. 31 Rest of the World Dry Eye Syndrome Market By Country (USD Million), 2019 - 2030
FIG. 32 Dry Eye Syndrome Market Type Rest of the World
FIG. 33 Dry Eye Syndrome Market Product Rest of the World
FIG. 34 Dry Eye Syndrome Market Distribution Channel Rest of the World
FIG. 35 Dry Eye Syndrome Middle East & Africa (MEA)outlook, 2019 & 2026
FIG. 36 Dry Eye Syndrome Latin America outlook, 2019 & 2026
FIG. 38 Global Dry Eye Syndrome Market: Research Methodology
FIG. 39 Top-Down and Bottom Up Approach
Companies Mentioned
Alimera Science
Allergan plc.,
Auven Therapeutics
Bausch + Lomb
GlaxoSmithKline plc
Nicox S.A.
Novartis AG
Otsuka Holdings Co. Ltd.
Santen Pharmaceutical Co. Ltd.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Global Dry Eye Syndrome Market Forces
3.1 Whats Driving the Market
3.2 Porters Five Forces Analysis
3.2.1 Power of Suppliers
3.2.2 Threats From New Entrants
3.2.3 Power of Buyer
3.2.4 Threat From Substitute Product
3.2.5 Degree of Competition
Chapter 4 Global Dry Eye Syndrome Market -Industry Snapshots
4.1 Overview
4.1.1 Global Dry Eye Syndrome Market Value, 2019 - 2030, (US$ Mn)
4.2 Market Overview
4.2.1 Drivers Analysis
4.2.2 Restraint/Challenges analysis
4.2.3 Opportunity Analysis
4.3 Supply Chain/Value Chain Analysis
4.4 Market SWOT Analysis
Chapter 5 Global Dry Eye Syndrome Market Analysis, By Type
5.1 Overview
5.2 Evaporative Dry Eye Syndrome
5.3 Aqueous Dry Eye Syndrome
Chapter 6 Global Dry Eye Syndrome Market Analysis, by Product
6.1 Overview
6.1.1 Anti-inflammatory
6.1.2 Artificial Tears
6.1.3 Lubricants
Chapter 7 Global Dry Eye Syndrome Market Analysis, by Distribution Channel
7.1 Overview
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.1.4 Others
Chapter 8 Dry Eye Syndrome Market Analysis by Region
8.1 Key Findings for Dry Eye Syndrome Market- By region
8.2 Overview
8.2.1 Global Dry Eye Syndrome Market Analysis, By Type, 2019 - 2030
8.2.2 Global Dry Eye Syndrome Market Analysis, By Product, 2019 - 2030
8.2.3 Global Dry Eye Syndrome Market Analysis, By Distribution Channel, 2019 - 2030
8.3 Dry Eye Syndrome Market North America
8.3.1 Overview
8.3.2 U.S.
8.3.3 Canada
8.3.4 Mexico
8.4 Dry Eye Syndrome Market Europe
8.4.1 Overview
8.4.2 Germany
8.4.3 United Kingdom
8.4.4 France
8.4.5 Italy
8.4.6 Rest Of Europe
8.5 Dry Eye Syndrome Market Asia Pacific
8.5.1 Overview
8.5.2 China
8.5.3 Japan
8.5.4 India
8.5.5 Rest of APAC
8.6 Dry Eye Syndrome Market Rest of the World
8.6.1 Overview
8.6.2 Middle East & Africa (MEA)
8.6.3 Latin America
Chapter 9 Market Competition Analysis
9.1 Market Share/Positioning Analysis
9.1.1 Market Positioning of Key Dry Eye Syndrome Vendors, 2018
9.1.2 Key Strategies Adopted by the Leading Players
Chapter 10 Company Profiles- Snapshot
10.1 Allergan
10.2 Novartis AG
10.3 Otsuka Pharmaceutical Co. Ltd.
10.4 Valent Pharmaceuticals
10.5 Johnson & Johnson Vision
10.6 Acadia Pharmaceutical
10.7 Allostera Pharma
10.8 I-Med Pharma Inc.
10.9 Santen Pharmaceuticals Co. Ltd.
10.10 AFT pharmaceuticals
10.11 Novaliq GmBh
10.12 Auven therapeutics
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies
Chapter 11 Appendix
11.1 Research Methodology
11.2 Data Triangulation
11.3 Data Sources
11.4 Assumptions
11.5 Approach Adopted
11.6 Disclaimer
List Of Tables
TABLE 1 Dry Eye Syndrome Market, By Evaporative Dry Eye Syndrome, 2018 - 2026 (USD Million)TABLE 2 Dry Eye Syndrome Market, By Aqueous Dry Eye Syndrome, 2018 - 2026 (USD Million)
TABLE 3 Dry Eye Syndrome Market By Anti-inflammatory, 2018 - 2026 (USD Million)
TABLE 4 Dry Eye Syndrome Market By Artificial Tears, 2018 - 2026 (USD Million)
TABLE 5 Dry Eye Syndrome Market By Lubricants, 2018 - 2026 (USD Million)
TABLE 6 Dry Eye Syndrome Market By Hospital Pharmacies, 2018 - 2026 (USD Million)
TABLE 7 Dry Eye Syndrome Market By Retail Pharmacies, 2018 - 2026 (USD Million)
TABLE 8 Dry Eye Syndrome Market By Online Pharmacies, 2018 - 2026 (USD Million)
TABLE 9 Dry Eye Syndrome Market By Others, 2018 - 2026 (USD Million)
TABLE 10 Global Dry Eye Syndrome Market Value, By Type, 2019 - 2030 (US$ Mn)
TABLE 11 Global Dry Eye Syndrome Market Value, By Product, 2019 - 2030 (US$ Mn)
TABLE 12 Global Dry Eye Syndrome Market Value, By Distribution Channel, 2019 - 2030 (US$ Mn)
TABLE 13 Dry Eye Syndrome Market Analysis by North America, By Country (USD Million), 2018-2026
TABLE 14 U.S. Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 15 U.S. Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 16 U.S. Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 17 Canada Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 18 Canada Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 19 Canada Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 20 Mexico Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 21 Mexico Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 22 Mexico Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 23 Dry Eye Syndrome Market Analysis by Europe by Country (USD Million), 2018-2026
TABLE 24 Germany Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 25 GermanyDry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 26 Germany Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 27 United Kingdom Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 28 United Kingdom Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 29 United Kingdom Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 30 France Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 31 France Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 32 France Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 33 Italy Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 34 Italy Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 35 Italy Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 36 Rest Of Europe Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 37 Rest Of Europe Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 38 Rest of Europe Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 39 Dry Eye Syndrome Market Analysis by Asia Pacific by Country (USD Million), 2018-2026
TABLE 40 China Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 41 China Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 42 China Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 43 Japan Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 44 Japan Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 45 Japan Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 46 IndiaDry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 47 IndiaDry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 48 India Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 49 Rest of APAC Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 50 Rest of APAC Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 51 Rest of APAC Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 52 Dry Eye Syndrome Market Analysis by Rest of the World , by Region(USD Million), 2018-2026
TABLE 53 Middle East & Africa (MEA)Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 54 Middle East & Africa (MEA)Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 55 Middle East & Africa (MEA)Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
TABLE 56 Latin America Dry Eye Syndrome Market, By Type, 2018 - 2026 (USD Million)
TABLE 57 Latin America Dry Eye Syndrome Market, By Product, 2018 - 2026 (USD Million)
TABLE 58 Latin America Dry Eye Syndrome Market, By Distribution Channel, 2018 - 2026 (USD Million)
List Of Figures
FIG. 1 Global Dry Eye Syndrome : Market SegmentationFIG. 2 Global Dry Eye Syndrome Market Value, 2019 - 2030, (US$ Mn)
FIG. 3 Global Dry Eye Syndrome Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 4 Global Dry Eye Syndrome Market Value Contribution, By Product, 2019 & 2026 (%)
FIG. 5 Global Dry Eye Syndrome Market Value Contribution, By Distribution Channel, 2019 & 2026 (%)
FIG. 6 Global Dry Eye Syndrome Market Value, 2019 - 2030, (US$ Mn)
FIG. 7 North America Dry Eye Syndrome Market By Country (USD Million), 2019 - 2030
FIG. 8 Dry Eye Syndrome By Type North America
FIG. 9 Dry Eye Syndrome Market By Product North America
FIG. 10 Dry Eye Syndrome By Distribution Channel North America
FIG. 11 Dry Eye Syndrome U.S. outlook, 2019 & 2026
FIG. 12 Dry Eye Syndrome Canada outlook, 2019 & 2026
FIG. 13 Dry Eye Syndrome Mexico outlook, 2019 & 2026
FIG. 14 Europe Dry Eye Syndrome Market By Country (USD Million), 2019 - 2030, (US$ Mn)
FIG. 15 Dry Eye Syndrome Market Type Europe
FIG. 16 Dry Eye Syndrome Market Product Europe
FIG. 17 Dry Eye Syndrome Market Distribution Channel Europe
FIG. 18 Dry Eye Syndrome Germany outlook, 2019 & 2026
FIG. 19 Dry Eye Syndrome United Kingdom outlook, 2019 & 2026
FIG. 20 Dry Eye Syndrome France outlook, 2019 & 2026
FIG. 21 Dry Eye Syndrome Italy outlook, 2019 & 2026
FIG. 22 Dry Eye Syndrome Rest Of Europe outlook, 2019 & 2026
FIG. 23 Asia Pacific Dry Eye Syndrome Market By Country (USD Million), 2019 - 2030
FIG. 24 Dry Eye Syndrome Market Type Asia Pacific
FIG. 25 Dry Eye Syndrome Market Product Asia Pacific
FIG. 26 Dry Eye Syndrome Market Distribution Channel Asia Pacific
FIG. 27 Dry Eye Syndrome China outlook, 2019 & 2026
FIG. 28 Dry Eye Syndrome Japan outlook, 2019 & 2026
FIG. 29 Dry Eye Syndrome India outlook, 2019 & 2026
FIG. 30 Dry Eye Syndrome Rest of APAC outlook, 2019 & 2026
FIG. 31 Rest of the World Dry Eye Syndrome Market By Country (USD Million), 2019 - 2030
FIG. 32 Dry Eye Syndrome Market Type Rest of the World
FIG. 33 Dry Eye Syndrome Market Product Rest of the World
FIG. 34 Dry Eye Syndrome Market Distribution Channel Rest of the World
FIG. 35 Dry Eye Syndrome Middle East & Africa (MEA)outlook, 2019 & 2026
FIG. 36 Dry Eye Syndrome Latin America outlook, 2019 & 2026
FIG. 38 Global Dry Eye Syndrome Market: Research Methodology
FIG. 39 Top-Down and Bottom Up Approach
Companies Mentioned
Alimera Science
Allergan plc.,
Auven Therapeutics
Bausch + Lomb
GlaxoSmithKline plc
Nicox S.A.
Novartis AG
Otsuka Holdings Co. Ltd.
Santen Pharmaceutical Co. Ltd.
RELATED REPORTS
Global Hepatitis Diagnostic Testing Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals Blood Banks Commercial Labs POC Locations
Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations The
View Report2024 Global PSA Testing Market Supplier Shares and Strategies Volume and Sales Segment Forecasts Emerging Opportunities
2024 Global PSA Testing Market: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Opportunities This unique report from provides information and analysis not available from any
View ReportGlobal Dry X-Ray Film Market 2023
Dry X-Ray film is cost-effective and environmentally friendly as it eliminates the need for chemical disposal. It possesses features such as outstanding grayscale and contrast, high resolution, and high density,
View ReportModerate and Severe Dry Eye Disease Market in China 2023
Dry eye disease is a common eye condition that occurs when the eyes do not produce enough tears or the tears evaporate too quickly. It can cause discomfort, irritation, and
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
